21 and older, any sex, with Peri-Implantitis. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Change of Marginal Bone LevelSecondary· Change from baseline at 6 and 12 months after the surgery
Change of marginal bone level on periapical standardized radiographs from baseline.
6 months
Group
Value
95% CI
Device Treatment
3.3
± 5.8
Sponsor's own description
Single arm study to evaluate the effectiveness of treatment approach using a new moldable beta-tricalcium phosphate(TCP) bone graft material and polylactide membrane in peri-implantitis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Other trials of easy-graft CLASSIC (beta-Tricalcium Phosphate)
Trials testing the same drug.
NCT03215667 — Ridge Preservation With Moldable Beta-tricalcium Phosphate Bone Substitute on Non-containable Non-Molar Extraction Sites
· NA
· terminated
Other recruiting trials for Peri-Implantitis
Currently open trials in the same condition.
NCT07012915 — Immunological-Clinical Evaluation of the Etiopathogenesis of Peri-Implantitis
· NA
· recruiting
NCT06679283 — Surgical Treatment of Peri-implantitis With Adjunctive Application of Platelet Rich Fibrin (PRF)
· NA
· recruiting
NCT06017817 — Antibacterial Photodynamic Therapy in the Management of Peri-implantitis
· NA
· recruiting
NCT06364982 — Distance Between Dental Implants as a Risk Indicator for Peri-implant Disease.
· recruiting
NCT06288919 — Erythritol vs Ultrasonic Scaler Prophylaxis Systems on Dental Implants With Crowns Made by Different Materials
· NA
· active not recruiting
Other Sunstar Americas trials
Trials by the same sponsor.
NCT04681885 — Evaluation of Toothbrush Bristles in Plaque Reduction
· NA
· completed
NCT04289051 — Clinical Evaluation of Oral Rinse for Xerostomia
· NA
· completed
NCT03215667 — Ridge Preservation With Moldable Beta-tricalcium Phosphate Bone Substitute on Non-containable Non-Molar Extraction Sites
· NA
· terminated
NCT02702609 — Assessment of Ridge Preservation Using Moldable Beta-tricalcium Phosphate Bone Grafting System
· NA
· completed
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sunstar Americas
Last refreshed: 8 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03213210.